Prevalence of nephropathy among diabetic patients in North American region: A systematic review and meta-analysis.

Autor:	Zahra S; Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom., Saleem MK; General Internal Medicine, University Hospital, Bristol and Weston NHS Foundation Trust, Royal College of Physicians and Surgeons of Glasgow, Glasgow, United Kingdom., Ejaz KF; Russell's Hall Hospital Dudley, Dudley, England., Akbar A; District Headquarter Hospital Jhelum Valley, Muzaffarabad, AJK, Pakistan., Jadoon SK; Combined Military Hospital/SKBZ, Muzaffarabad, AJK, Pakistan., Hussain S; Medicine (AJKMC), Fellow Endocrinology Capital Hospital Islamabad, Islamabad, Pakistan., Ali AI; Consultant Surgeon, Combined Military Hospital/SKBZ, Muzaffarabad, AJK, Pakistan., Ifty M; School of Pharmacy, Brac University, Dhaka, Bangladesh., Jannati SZ; School of Pharmacy, Brac University, Dhaka, Bangladesh., Armin F; School of Pharmacy, Brac University, Dhaka, Bangladesh., Sarker D; School of Pharmacy, Brac University, Dhaka, Bangladesh., Islam DZ; Department of Microbiology, Jahangirnagar University, Dhaka, Bangladesh., Khandker SS; Department of Microbiology, Gonoshasthaya Samaj Vittik Medical College, Dhaka, Bangladesh., Khan MS; Department of Medicine DHQ Teaching, Hospital Kotli AJK, Kotli, Pakistan., Alvi S; Teaching Faculty, University of Khartoum, Khartoum, Sudan.
Jazyk:	angličtina
Zdroj:	Medicine [Medicine (Baltimore)] 2024 Sep 20; Vol. 103 (38), pp. e39759.
DOI:	10.1097/MD.0000000000039759
Abstrakt:	Background: Nephropathy is one of the most common microvascular impediments of diabetes mellitus. In this study, we aimed to estimate the prevalence of nephropathy in diabetic patients across the North American region. Methods: Eligible studies were screened out from 3 electronic databases, for example, PubMed, Google Scholar, and ScienceDirect using specific search keywords based on the eligibility criteria. Extracting the data from the included studies publication bias, quality assessment, outlier investigation, and meta-analysis was done followed by the subgroup analysis. A total of 11 studies met the study inclusion criteria. Meta-analysis was performed with the extracted data. Results: Pooled prevalence of 28.2% (95% confidence interval [CI]: 19.7-36.7) with a high rate of heterogeneity (I2 = 100%) was identified. The pooled prevalence of nephropathy among diabetic patients in the United States of America, Canada, and Mexico was 24.2% (95% CI: 13.8-34.5), 31.2% (95% CI: 25.8-36.5), and 31.1% (95% CI: 20.8-41.5), respectively. Conclusion: The prevalence of nephropathy among diabetic patients was found lower in the United States of America as compared to Canada and Mexico. Besides, the pooled prevalence of the North American region was found to be lower as compared to the African, European, and Asian regions. Minimizing the pathogenic factors, sufficient diagnostic, healthcare facilities, and awareness are recommended to improve the situation. Competing Interests: The authors have no conflicts of interest to disclose. (Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu